CLOV vs CTAS
Clover Health Investments Corp (CLOV) versus Cintas Corporation (CTAS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Cintas Corporation (CTAS) is a specialty business services company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported CTAS revenue for 2025-05-31 was $10.34B. Net income was $1.81B. Revenue was up 7.7% from 2024-05-31 to 2025-05-31. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
CLOV currently screens at market cap $1.55B. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
Not investment advice. Open the CLOV and CTAS stock pages for the full models.
Not investment advice.